Ezetimibe 3-O-Acetyl Impurity
 
		Product Description
CAT No.
				
									ALN-E026021								
				CAS No.
				
									190448-46-5								
				Mol. F.
				
									C26H23F2NO4								
				Mol. Wt.
				
									451.5								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (S)-1-(4-Fluorophenyl)-3-((2S,3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxoazetidin-3-yl)propyl acetate								
				
									Smiles : FC1=CC=C([C@@H](OC(C)=O)CC[C@H]2C(N(C3=CC=C(F)C=C3)[C@@H]2C4=CC=C(O)C=C4)=O)C=C1								
				
									Inchi : InChI=1S/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2/t21-,22+,23-/m0/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Related substances by HPLC method for the detection and evaluation of impurities in ezetimibe drug material
									By Rapeti, Durgababu; Reddy, Gudibanda Chandra Sekhar; Narayanarao, Kapavarapu Maruthi Venkata; Shyamala, Pulipaka; Krishna, Rallabhandi MuralinFrom International Journal of Pharmaceutical Sciences and Research (2021), 12(1), 217-225								
				Stability-indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples
									By Kurbanoglu, Sevinc; Esim, Ozgur; Ozkan, Cansel Kose; Savaser, Ayhan; Ozkan, Yalcin; Uslu, Bengi; Ozkan, Sibel A. – From Journal of the Turkish Chemical Society, Section A: Chemistry (2020), 7(3), 865-874 								
				Stability-indicating analytical method development using quality by design approach for simultaneous estimation of ezetimibe and glimepiride
									By Shah, U.; Shah, Kunti; Patel, Rupal – From Indian Journal of Pharmaceutical Sciences (2019), 81(2), 273-281								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            